Loading...

Advancing Myopia Management Will Unlock Global MedTech Potential

Published
16 Feb 25
Updated
04 Oct 25
AnalystConsensusTarget's Fair Value
€283.63
1.7% undervalued intrinsic discount
04 Oct
€278.70
Loading
1Y
30.5%
7D
0.7%

Author's Valuation

€283.631.7% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Shared on04 Oct 25
Fair value Increased 2.17%

Analysts have raised their price target for EssilorLuxottica Société anonyme from €277.61 to €283.63. They cited the company’s strong competitive positioning, expansion into new markets, and opportunities for sustainable growth.

Shared on19 Sep 25
Fair value Increased 4.39%

Analysts have raised EssilorLuxottica's price target to €277.61, citing its dominant market position, strong growth prospects in new markets, and robust vertical integration as key drivers for upward value revision. Analyst Commentary Bullish analysts cite EssilorLuxottica's unrivalled position in structurally attractive optical markets as a key growth driver.

Shared on04 Sep 25

With consensus forecasts for both revenue growth (6.1% per annum) and discount rate (7.01%) unchanged, there is no revision to the analyst fair value target for EssilorLuxottica, which remains at €265.94. What's in the News EssilorLuxottica and Meta Platforms have launched Oakley Meta, a new line of performance-focused AI smart glasses featuring advanced PRIZM lens technology, Ultra HD 3K recording, open-ear speakers, significantly longer battery life, and a smart charging case (Key Developments, 2025-06-20).